Eradication of unresectable liver metastasis through induction of tumour specific energy depletion
Treatment of liver metastasis in cancer patients is associated with severe side effects. Here, the authors develop nucleus and mitochondria targeted nanoparticles, conjugated via a cathepsin B sensitive peptide to selectively target liver metastatic cells.
Main Authors: | Da Huo, Jianfeng Zhu, Guojun Chen, Qian Chen, Chao Zhang, Xingyu Luo, Wei Jiang, Xiqun Jiang, Zhen Gu, Yong Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11082-3 |
Similar Items
-
Induction chemotherapy in recurrent, unresectable esthesioneuroblastoma
by: Sachin Dhumal, et al.
Published: (2018-01-01) -
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
by: Hongjun Li, et al.
Published: (2021-05-01) -
Adverse reaction of a combined treatment for unresectable liver cancer
by: Ren Jianjun, et al.
Published: (2014-04-01) -
Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis
by: Ky Thai Doan, et al.
Published: (2020-01-01) -
Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
by: Shu-Yi Yin, et al.
Published: (2016-04-01)